Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Multimedia Aid for Genetic Testing in Gynecologic Oncology [NA]
A clinical trial update about a multimedia aid to improve genetic testing uptake in gynecologic cancers. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin [Phase 2]
Phase 2 clinical trial evaluating belzutifan for recurrent clear cell carcinoma of gynecologic origin is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer [NA]
Pilot randomized controlled trial evaluating a collaborative agenda-setting intervention (CASI) for patients with ovarian cancer. The study …
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for BL-M17D1 in patients with HER2-expressing or HER2-mutant advanced or metastatic solid tumors; the study is…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy [Phase 3]
Phase 3 randomized trial comparing two dosing schedules for hypofractionated image-guided radiation therapy in melanoma and ovarian cancer. …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. [Phase 1, Phase 2]
A Phase 1a/1b clinical trial evaluating TILT-123 (oncolytic adenovirus) with pembrolizumab, and with pegylated liposomal doxorubicin, for pl…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Clinical Pre-screening Protocol for Ovarian Cancer
Allarity Therapeutics reports an ongoing clinical trial evaluating a pre-screening protocol for ovarian cancer; the study is currently recru…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Genetic Education in BRCA Families [NA]
A Georgetown University-sponsored clinical trial focused on genetic education in BRCA families is currently enrolling by invitation for part…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: A Trial of Vigil for Participants With Ovarian Cancer [Phase 2]
Phase 2 trial update for Gradalis' Vigil in ovarian cancer, noting the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating mirvetuximab soravtansine with carboplatin for FRα-expressing, platinum-sensitive epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating senaparib in combination with temozolomide for ARID1A mutation–associated ovarian cancer and related perit…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: The Better, Harder, Faster, Stronger Study
Wake Forest University Health Sciences reports that its study titled 'The Better, Harder, Faster, Stronger Study' is currently recruiting, i…
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer
This update describes an active-not-recruiting clinical trial at the Abramson Cancer Center investigating polygenic risk scores and multi-ca…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) [Phase 2, Phase 3]
A Phase 2/3 trial evaluating the diagnostic performance of GEH300079 (68Ga) PET/CT for detecting pancreatic cancer in patients with colorect…
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients [NA]
A Memorial Sloan Kettering Cancer Center study to develop educational materials about genetic testing for a diverse group of cancer patients…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer [Phase 2]
This is a Phase 2 open-label, single-arm trial evaluating autologous M-CENK adoptive cell therapy with IL-15 superagonist N-803 in combinati…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer [NA]
This clinical trial update describes the IM@HOME Integrative Medicine at Home program for cancer patients and indicates that recruitment is …
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: No-Stoma Policy in Advanced Ovarian Cancer Surgery [NA]
A clinical trial investigating a no-stoma policy in surgery for advanced ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer: [Phase 3]
Phase 3 clinical trial is investigating whether transcutaneous auricular vagus nerve stimulation improves quality of life for patients recei…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
Memorial Sloan Kettering Cancer Center is piloting an alternative genetics-based cancer care delivery model and assessing patient outcomes; …
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study [NA]
A clinical trial update on the Pre_ERAS study evaluating prehabilitation within ERAS protocols for gynecologic oncology surgery; the trial i…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer [Phase 2]
Phase 2 clinical trial update for CBX 12 in platinum-resistant or refractory ovarian cancer, sponsored by Cybrexa Therapeutics, currently re…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC [Phase 2]
Phase 2 window-of-opportunity trial evaluating combination therapy with Olaparib and Durvalumab in histologically proven epithelial ovarian …
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Trial on Radical Upfront Surgery in Advanced Ovarian Cancer [NA]
This entry notes a clinical trial sponsored by the AGO Study Group evaluating radical upfront surgery for advanced ovarian cancer; the trial…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating infusion of NY-ESO-1–specific TCR-engineered lymphocytes in patients with NY-ESO-1-expressing…